Cdk9 phosphorylates p53 on serine 392 independently of CKII

被引:47
作者
Claudio, Pier Paolo
Cui, Jianqi
Ghafouri, Mohammad
Mariano, Chiara
White, Martyn K.
Safak, Mahmut
Sheffield, Joel B.
Giordano, Antonio
Khalili, Kamel
Amin, Shohreh
Sawaya, Bassel E.
机构
[1] Temple Univ, Ctr Biotechnol, Dept Biol, Coll Sci & Technol,Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA
[2] Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA
[3] Temple Univ, Dept Neurosci, Sch Med, Ctr Neurovirol, Philadelphia, PA 19140 USA
关键词
D O I
10.1002/jcp.20698
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The tumor suppressor p53 is an important cellular protein, which controls cell cycle progression. Phosphorylation is one of the mechanisms by which p53 is regulated. Here we report the interaction of p53 with another key regulator, cdk9, which together with cyclin T1 forms the positive transcription elongation complex, p-TEFb. This complex cooperates with the,HIV-1 Tat protein to cause the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase 11 and this facilitates the elongation of HIV-1 transcription. We demonstrate that cdk9 phosphorylates p53 on serine 392 through their direct physical interaction. Results from protein-protein interaction assays revealed that cdk9 interacts with the C-terminal domain (aa 361-393) of p53, while p53 interacts with the N-terminal domain of cdk9. Transfection and protein binding assays (EMSA and ChIP) demonstrated the ability of p53 to bind and activate the cdk9 promoter. Interestingly, cdk9 phosphorylates serine 392 of p53, which could be also phosphorylated by casein kinase II. Kinase assays demonstrated that cdk9 phosphorylates p53 independently of CKII. These studies demonstrate the existence of a feedback-loop between p53 and cdk9, pinpointing a novel mechanism by which p53 regulates the basal transcriptional machinery.
引用
收藏
页码:602 / 612
页数:11
相关论文
共 64 条
[1]   p53-Mdm2 - the affair that never ends [J].
Alarcon-Vargas, D ;
Ronai, Z .
CARCINOGENESIS, 2002, 23 (04) :541-547
[2]   p73 interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28 [J].
Amini, S ;
Mameli, G ;
Del Valle, L ;
Skowronska, A ;
Reiss, K ;
Gelman, BB ;
White, MK ;
Khalili, K ;
Sawaya, BE .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (18) :8126-8138
[3]   Interplay between HIV-1 Vpr and Sp1 modulates p21WAF1 gene expression in human astrocytes [J].
Amini, S ;
Saunders, M ;
Kelley, K ;
Khalili, K ;
Sawaya, BE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :46046-46056
[4]   Interplay between cdk9 and NF-κB factors determines the level of HIV-1 gene transcription in astrocytic cells [J].
Amini, S ;
Clavo, A ;
Nadraga, Y ;
Giordano, A ;
Khalili, K ;
Sawaya, BE .
ONCOGENE, 2002, 21 (37) :5797-5803
[5]  
Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
[6]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[7]   p53: 25 years of research and more questions to answer [J].
Bourdon, JC ;
De Laurenzi, V ;
Melino, G ;
Lane, D .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (04) :397-399
[8]   Flavopiridol inhibits P-TEFb and blocks HIV-1 replication [J].
Chao, SH ;
Fujinaga, K ;
Marion, JE ;
Taube, R ;
Sausville, EA ;
Senderowicz, AM ;
Peterlin, BM ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28345-28348
[9]   Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines [J].
De Falco, G ;
Neri, LM ;
De Falco, M ;
Bellan, C ;
Yu, ZL ;
De Luca, A ;
Leoncini, L ;
Giordano, A .
ONCOGENE, 2002, 21 (49) :7464-7470
[10]   Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation [J].
De Falco, G ;
Bagella, L ;
Claudio, PP ;
De Luca, A ;
Fu, Y ;
Calabretta, B ;
Sala, A ;
Giordano, A .
ONCOGENE, 2000, 19 (03) :373-379